The Six-Year Ban: Ruti Aga and the Unwritten Silence of the Marathon World

At a little past midnight in March, on the finish line of a label road race somewhere in China, Ruti Aga must have cut the tape and celebrated. The time of that race never appeared in any newspaper. The photographs from that race never reached an Indian desk. The very race that gave her another cheque and another medal was destined to end her career — because the urine sample collected after it came back positive. The Athletics Integrity Unit (AIU) issued a statement on Thursday announcing a six-year ban. A world that argues over photo-finishes in finals reduced this news to a single paragraph.

This piece is an attempt to expand that paragraph — not for sympathy, not to lessen the punishment, but because the technical and administrative failures in this case mirror the very structure of Indian athletics that I have covered for a decade.

First, correct what the media got wrong. The reports that described Aga as sanctioned for a "prohibited steroid" misclassified methylprednisolone. It is not an anabolic steroid; it is a glucocorticoid, listed under Category S9 of the WADA Prohibited List, and S9 substances are prohibited in-competition only (by injection, oral, or rectal route). Which means: a therapeutic injection given to the knee, if administered sufficiently before competition, is entirely legal. This technical distinction is the key to the whole case — and without understanding it, the news makes no sense.

I have worked on the athletics desk since 2026, and I have learned one thing: whenever an East African runner faces a doping charge, the first question is not "did they take it?" The first question is "who was watching?" And the second is "did they have a doctor?" In Aga's case, the answer to the third question is very clear: no.

The Story of That Knee, Which Became a Prescription

In her defence, Aga said she had a knee injury and was given methylprednisolone for treatment. That claim is medically entirely credible. Intra-articular glucocorticoid injections for knee inflammation and synovitis are standard sports-medicine practice in distance runners — I have seen athletes return from such injections at middle-distance camps in Kerala and in the dormitories of NIS Patiala. Suppressing pain to save a season is the story of every athlete whose income depends on appearance fees.

But the real turn comes where medicine ends and paperwork begins. What emerged from the AIU investigation was no simple oversight. The prescription Aga submitted was issued by a clinic that did not exist. The "doctor" who wrote it was a family member with no medical registration. When questioned, that person claimed to have used "an old prescription pad from a former workplace" — which the clinic explicitly disowned.

This is a three-level failure, and all three point in the same direction: an athlete who is part of the world's deepest marathon system had no credentialled team physician. No TUE application. No washout calculation. There was a knee, there was an injection, and there was a solution manufactured with a forged slip.

Two Years versus Six: Where Does the Arithmetic Come From?

Here, for readers unfamiliar with the structure of anti-doping cases, a clarification is necessary. The six-year ban AIU issued is not the penalty for a single violation. It is the sum of two separate violations.

First: two years for the presence of the substance. This is a standard sanction under the WADA Code, especially for substances classed as "Specified Substances" — and glucocorticoids fall in this category. This means the panel held that this was not a deliberate attempt at performance enhancement, but a case of therapeutic use not properly documented.

Second: four years for tampering. This penalty applies when an athlete submits false documents or provides misleading information during an investigation. According to the AIU statement, this violation emerged during an interview — meaning it came from Aga's own statements, not merely from paper.

Two and four, six. The arithmetic is clear. But what is concealed within it is this: had she possessed genuine medical records, this case would likely have been under two years — or no case at all. A glucocorticoid is prohibited only in-competition. A correctly timed injection, with proper documentation, could have stood before any panel. But Aga chose the path that looked fastest — and it cost the most.

This reminds me of my own experience in 2026, when PUBG Mobile was banned and I went dark for eleven days. At the time I thought the story was over. Later I understood that stories do not end — their structure just changes. Something similar happened with Aga. The moment she submitted the forged slip, she shattered her strongest defence — medical necessity — with her own hands.

Age Thirty-Two, a Six-Year Ban, and That Eight-Year Window

Aga is 32 now. When her ban ends, she will be roughly 38. In women's marathon, particularly in Ethiopia's depth where even a 2:18 is not automatic selection, a 38-year-old with a doping record is practically unselectable. This six-year ban is six years on paper, but in practice it is career termination.

But there is another thing here that must not be overlooked. Aga's 2026 Tokyo Marathon victory — the biggest achievement of her career — is not affected by this ban. The sanction is anchored to the March race in China, and absent evidence of prior violation, results before 2026 are not automatically annulled. The AIU statement does not specify the disqualification scope, but standard practice means the March race result and prize money should be considered void.

This case is bigger than an individual tragedy. It is a portrait of a whole system in which injured marathoners have strong economic incentives to hide pain — because if you miss an event, your appearance fee is gone. Glucocorticoids are the cheapest, most available tool for that concealment. And when medical support is informal, a paper workaround becomes the next logical step. The forged slip was not a beginning; it was a symptom of a system that never provided a real alternative.

What I Learned During the Pandemic Is Relevant Now

I am among those who saw in 2026 how a government order can end a four-person team in a week. At the time I was hosting an online cup from my bedroom in Kolkata, with 40 viewers, while cable carried empty stadiums and postponed National Games. I stayed silent for eleven days. No posts, no casts. The story I had idealized was simply removed by a ministry on a Tuesday.

After that I changed my method. I stopped writing hero stories around organisations and started writing about contracts, notice periods, and who actually pays a 19-year-old when the game ends. The prose became plainer, but the emotional passages that survived were earned, not assumed.

The same question applies to Aga's case. When we read about a runner's six-year ban, we should also ask: who paid for her knee treatment? What role did her agent play? When she had that slip made, was there a professional with her who could have said "stop, this is wrong"? The AIU statement names only the family member. There is no mention of investigation into the agent or management. That silence is itself a signal.

Is the Punishment Proportional?

Now comes the turn where I must disagree with my readers — and this disagreement centres on the most important part of this case.

Many will say six years is too much. I would say: arithmetically it is standard, but morally it leaves an uncomfortable question. Methylprednisolone is a substance with no proven performance-enhancing benefit for endurance. It reduces pain and inflammation, that is all. Even if Aga took that injection, she took it not for a technical edge but to be able to run. And yet she received six years — while some anabolic steroid cases have seen four-year sanctions.

This discrepancy will fuel the debate about AIU's rigor versus its targeting of African road runners. I do not wish to take sides, but I will say this: the real message of the sanction is not that glucocorticoids are dangerous; the message is that document tampering is more dangerous than the substance being concealed. Aga converted a possible two-year sanction into six, and it all happened because of a slip of paper.

But there is a nuance I cannot overlook. The interview portion of AIU's investigation depended on language and translation conditions. I have seen in many East African athlete cases that when interviews are conducted in English or French, nuances are lost. This does not reduce the sanction, but it is a factor that would be wrong to ignore entirely.

China's Label Circuit and the Emerging Risk Zone

Here is something very few are noticing. Aga's positive sample was collected after a half marathon in China in March. China's label road race circuit has become a massive economic opportunity for East African marathoners — large appearance fees, deep elite fields, and an attractive income tier between Majors. That same tier is now becoming AIU's highest-yield testing ground.

The appearance-fee economy and the testing economy are colliding in the same race. The race that pays a runner the most also creates the greatest risk of ending their career. And when medical support is informal, that risk multiplies. I expect more similar cases to surface in the coming months, because informal medical networks serving one training group often serve others too.

The Question No One Asks

Aga's case is not a photo-finish. There is no 0.01-second gap, no fourth place to cry over. It is a case in which a 32-year-old runner, in the final stretch of her career, made a mistake she may never understand — and which we, spectators and journalists, will dismiss in a paragraph.

But perhaps we should ask a question we rarely ask: when an athlete has a fake prescription made, is she alone? Or is she a product of a system that never gave her a real doctor, a real TUE process, and real support? Aga has been punished. But who treated that knee, and who paid the bill — that question is still hanging in the air.

Next time you watch a marathon finish line, look at the runner bending to rub her knee after the victory. You might see an injection there, and behind that injection a story no one is writing.